CD33 in Alzheimer's Disease
- 28 August 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in Molecular Neurobiology
- Vol. 49 (1), 529-535
- https://doi.org/10.1007/s12035-013-8536-1
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Variants in the ATP-Binding Cassette Transporter (ABCA7), Apolipoprotein E ε4, and the Risk of Late-Onset Alzheimer Disease in African AmericansJAMA, 2013
- Association and heterogeneity at the GAPDH locus in Alzheimer's diseaseNeurobiology of Aging, 2012
- Targeting Siglecs—A novel pharmacological strategy for immuno- and glycotherapyBiochemical Pharmacology, 2011
- Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's diseaseNature Genetics, 2011
- Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's diseaseNature Genetics, 2011
- Inflammation, microglia, and alzheimer's diseaseNeurobiology of Disease, 2010
- Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapyNature Reviews Neuroscience, 2009
- Genome-wide Association Analysis Reveals Putative Alzheimer's Disease Susceptibility Loci in Addition to APOEAmerican Journal of Human Genetics, 2008
- Siglecs and their roles in the immune systemNature Reviews Immunology, 2007
- No Gene Is an Island: The Flip-Flop PhenomenonAmerican Journal of Human Genetics, 2007